Normand Beaulieu

Senior Scientist at SemaThera Inc - Westmount, QC, CA

Normand Beaulieu's Colleagues at SemaThera Inc
Francois Binet

Senior Principal Scientist

Contact Francois Binet

Garth Cumberlidge

President, Director & Chief Executive Officer

Contact Garth Cumberlidge

Normand Beaulieu's Contact Details
HQ
N/A
Location
Montreal, Quebec, Canada
Company
SemaThera Inc
Normand Beaulieu's Company Details
SemaThera Inc logo, SemaThera Inc contact details

SemaThera Inc

Westmount, QC, CA • 5 - 9 Employees
BioTech/Drugs

SemaThera is a spin-off company from AmorChem Fund 1, which focuses on a novel target, semaphorin 3A (SEMA3A). The Company is currently developing bispecific SEMA3A / VEGF inhibitors (traps) to prevent vascular leakage and damper the inflammation in diabetic macular edema (DME). The technology targets the 30% DME patients who are poor responders to current anti-VEGF therapies.

diabetic macular edema ocular diseases semaphorin 3A
Details about SemaThera Inc
Frequently Asked Questions about Normand Beaulieu
Normand Beaulieu currently works for SemaThera Inc.
Normand Beaulieu's role at SemaThera Inc is Senior Scientist.
Normand Beaulieu's email address is ***@semathera.com. To view Normand Beaulieu's full email address, please signup to ConnectPlex.
Normand Beaulieu works in the BioTech/Drugs industry.
Normand Beaulieu's colleagues at SemaThera Inc are Francois Binet, Véronique Bougie, Garth Cumberlidge, Michelle Barbagallo and others.
Normand Beaulieu's phone number is N/A
See more information about Normand Beaulieu